Kurzrock R - Search Results

1

Clinical development of farnesyltransferase inhibitors in leukemias and myelodysplastic syndrome.

Kurzrock R, Cortes J, Kantarjian H. Kurzrock R, et al. Semin Hematol. 2002 Oct;39(4 Suppl 3):20-4. doi: 10.1053/shem.2002.36925. Semin Hematol. 2002. PMID: 12447848 Review.

2

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).

Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO, et al. Estey EH, et al. Among authors: kurzrock r. Blood. 1992 Feb 15;79(4):882-7. Blood. 1992. PMID: 1346577 Free article.

3

Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia.

Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU. Talpaz M, et al. Among authors: kurzrock r. Cancer. 1992 Jan 15;69(2):410-2. doi: 10.1002/1097-0142(19920115)69:2<410::aid-cncr2820690222>3.0.co;2-v. Cancer. 1992. PMID: 1370212

4

Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M. Dhingra K, et al. Among authors: kurzrock r. Leukemia. 1992 Aug;6(8):754-60. Leukemia. 1992. PMID: 1640725

5

Fludarabine therapy in macroglobulinemic lymphoma.

Kantarjian HM, Alexanian R, Koller CA, Kurzrock R, Keating MJ. Kantarjian HM, et al. Among authors: kurzrock r. Blood. 1990 May 15;75(10):1928-31. Blood. 1990. PMID: 1692487 Free article.

6

Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity.

Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D, Gutterman JU, Talpaz M. Estrov Z, et al. Among authors: kurzrock r. Blood. 1991 Sep 15;78(6):1476-84. Blood. 1991. PMID: 1715791 Free article.

7

Interferon-stimulated genes in interferon-sensitive and -resistant chronic myelogenous leukemia patients.

Talpaz M, Chernajovsky Y, Troutman-Worden K, Wetzler M, Kantarjian H, Gutterman JU, Kurzrock R. Talpaz M, et al. Among authors: kurzrock r. Cancer Res. 1992 Mar 1;52(5):1087-90. Cancer Res. 1992. PMID: 1737366

8

Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro.

Estrov Z, Kurzrock R, Talpaz M, Blake M, Gutterman JU. Estrov Z, et al. Among authors: kurzrock r. Ann Hematol. 1991 Dec;63(6):297-301. doi: 10.1007/BF01709650. Ann Hematol. 1991. PMID: 1756190

9

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia.

Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M. Schilling PJ, et al. Among authors: kurzrock r. Cancer. 1991 Oct 1;68(7):1536-7. doi: 10.1002/1097-0142(19911001)68:7<1536::aid-cncr2820680713>3.0.co;2-b. Cancer. 1991. PMID: 1893353

10

A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia.

Talpaz M, Kurzrock R, Kantarjian H, Rothberg J, Saks S, Evans L, Gutterman JU. Talpaz M, et al. Among authors: kurzrock r. Cancer. 1991 Nov 15;68(10):2125-30. doi: 10.1002/1097-0142(19911115)68:10<2125::aid-cncr2820681006>3.0.co;2-q. Cancer. 1991. PMID: 1913450 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

976 results

Search Page